Which tumours are contraindications to follitropin delta treatment?

Rekovelle (follitropin delta) is contraindicated in hypothalamic or pituitary tumours and ovarian, uterine or mammary carcinoma; it also should not be administered for uterine fibroid tumours incompatible with pregnancy because treatment outcome is unlikely to be favourable.